Protein kinase C (PKC) activators, such as the
tumor-promoting
phorbol esters, have been reported to protect several cell lines from apoptosis induced by a variety of agents. Recent evidence suggests that PKCepsilon is involved in protection of cardiac myocytes from
hypoxia-induced cell death (Gray, M. O., Karliner, J. S., and Mochly-Rosen, D. (1997) J. Biol. Chem. 272, 30945-30951). We investigated the protective effects of the
phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) on U937
histiocytic lymphoma cells induced to undergo apoptosis by
tumor necrosis factor-alpha (
TNF-alpha) or by the specific PKC inhibitor
calphostin C. U937 cells were transiently permeabilized with a
peptide (epsilonV1-2) derived from the V1 region of PKCepsilon that has been reported to specifically block translocation of PKCepsilon. The
epsilonV1-2 peptide blocked the inhibitory effect of TPA on both
TNF-alpha- and
calphostin C-induced apoptosis. A scrambled version of epsilonV1-2 and a
peptide reported to inhibit PKCbeta translocation (betaC2-4) had no effect on the ability of TPA to inhibit apoptosis. These results suggest that PKCepsilon is required for the protective effect of TPA in
TNF-alpha- and
calphostin C-induced apoptosis. Furthermore,
calphostin C reduced membrane-associated PKCepsilon activity and immunoreactivity, suggesting that PKCepsilon may play an important role in leukemic cell survival.